| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.7B | $0.7B | $0.6B | $0.6B | $0.6B | $0.4B | $0.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| Net Income | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $-0.0B | $0.0B |
| EPS (Basic) | $2.93 | $2.87 | $2.69 | $2.44 | $2.04 | $0.47 | $-0.20 | $0.38 |
| EPS (Diluted) | $2.92 | $2.87 | $2.68 | $2.43 | $2.03 | $0.46 | $-0.19 | $0.38 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.1B | $4.7B | $4.3B | $3.6B | $3.5B | $3.3B | $3.1B | $2.0B |
| Current Assets | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.5B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $0.3B | $0.3B | $0.3B | $0.3B | $0.2B | $0.4B | $0.2B | $0.2B |
| Stockholders' Equity | $1.5B | $1.4B | $1.2B | $1.1B | $1.0B | $0.9B | $0.9B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.5B | $-0.3B | $-0.3B | $-0.2B | $-0.3B | $-0.2B | $-1.0B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.3B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.5B | $0.5B |